Adalta Capital Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Adalta Capital Management’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$569K	Buy	+37,080	New	+$533K	0.25%	62

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Adalta Capital Management's BMEZ Position: Q2 2026 in Review

Adalta Capital Management opened a new position in BlackRock Health Sciences Trust II (BMEZ) in Q2 2026: 37,080 shares worth $569K. The stake represents 0.25% of the portfolio and ranks #62 among its holdings.

88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

Adalta Capital Management held 37,080 shares of BlackRock Health Sciences Trust II worth $569K as of Q2 2026.
BlackRock Health Sciences Trust II was a new Adalta Capital Management position in Q2 2026.
BlackRock Health Sciences Trust II made up 0.25% of Adalta Capital Management's portfolio in Q2 2026, its #62 holding.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Adalta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.